Grant of share options and restricted share units
Filed with HKEX · Stock code 2616 · · 9 pages · English
Summary by 6ix AI
CStone Pharmaceuticals has announced the grant of share options and restricted share units to employees under its Post-IPO schemes. The grants aim to incentivize employees and align their interests with those of shareholders. The announcement is made in compliance with the Listing Rules of the Hong Kong Stock Exchange.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from CStone Pharmaceuticals
- Monthly return of equity issuer on movements in securities for the month ended 31 October 2026
- Voluntary announcement - cstone and kimia therapeutics enter clinical development collaboration to advance a novel drug candidate targeting repair pathways critical for solid tumor survival
- Voluntary announcement - cstone announces major clinical validation milestone for CS2009 at ESMO 2026: data from more than 300 patients support mechanism, safety and broad antitumor activity
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- Interim report 2026
Follow CStone Pharmaceuticals into a list and get an email when it puts out news.
Follow CStone Pharmaceuticals